Catheter Stabilization Device/Catheter Securement Device Market

Executive Summary

Catheter Stabilization Device/Catheter Securement Device Market was valued at US $1.33 billion in 2021 and is projected to grow at 10.92% CAGR over the forecast period to reach US $2.48 billion by 2027. Catheter Stabilization Device/Catheter Securement Device Market represented US $0.25 billion opportunity over 2019-2021 and estimated to create US $1.15 billion opportunity in 2027 over 2021.

Catheter Stabilization Device/Catheter Securement Device from Consainsights analyses the Catheter Stabilization Device/Catheter Securement Device Market in the Life Sciences industry over the forecast period to 2027.

Catheter Stabilization Device/Catheter Securement Device research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Catheter Stabilization Device/Catheter Securement Device segmentation includes Type, Application, End User and Geography.

Based on the Type, the Catheter Stabilization Device/Catheter Securement Device analysis covers Peripheral Catheter Securement Devices, Central Venous Catheter Securement Devices, Arterial Catheter Securement Devices, Chest Drainage Tube Securement Devices, Abdominal Drainage Tube Securement Devices, Epidural Securement Devices, All-site Securement Devices.

In Type segment, Peripheral Catheter Securement Devices segment has highest cagr growth of 9.65%.

Based on the Application, the Catheter Stabilization Device/Catheter Securement Device analysis covers Cardiovascular Procedures, Respiratory Procedures, Gastric And Oropharyngeal Procedures, General Surgery, Urological Procedures, Radiology, Other Applications.

In Application segment, Cardiovascular Procedures segment has highest cagr growth of 9.65%.

Based on the End User, the Catheter Stabilization Device/Catheter Securement Device analysis covers Hospitals, Homecare Settings, Emergency Clinics, Diagnostic Imaging Centers.

In End User segment, Hospitals segment has highest cagr growth of 9.65%.

Based on the region, the Catheter Stabilization Device/Catheter Securement Device analysis covers North America, Europe, Asia-Pacific, Middle-East & Africa, Latin America.

Key companies operating in the market include 3m Company, B Braun Melsungen Ag, Baxter International, C.R. Bard (Becton Dickinson And Company), Centurion Medical Products (Medline), Convatec, Inc., Mc Johnson Company Inc., Merit Medical Systems Inc., Cardinal Health, Inc., Smiths Group Plc and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Market Overview

Definition & Scope

The base currency considered was the US Dollar (USD). Conversion of other currencies to USD was considered on the basis of the average exchange rate for the respective review-period years. The exchange rate conversion for forecast period was determined according to the base year’s conversion rates.

The base year was identified based on the availability of annual reports and secondary information. The base year considered for this study is 2027.

The review period considered for this study is from 2018-2027. The CAGR is for the forecast period, 2022-2027.

Market size estimations for the forecast years were in real terms. Inflation is not part of the pricing, and the average selling price (ASP) was kept constant throughout the forecast period for each country.

Distribution of primary interviews conducted was based on the regional share of the market and the presence of key players in each region.

As a result of data triangulation through multiple methodologies and approaches, the weighted averages of resulting estimates were considered to be the final values.

Currency, Year & Forecast

The currency used in this report is USD, with the market size indicated in terms of USD million/billion.

For companies reporting their revenues in USD, the revenues were taken from their respective annual reports/SEC filings.

For companies reporting their revenues in other currencies, the average annual currency conversion rates were used for a particular year to convert the value to USD Market Definition.

Type

Introduction

In 2021, Peripheral Catheter Securement Devices segment has the highest revenue of US $0.51 billion and is expected to grow at CAGR of 9.65% by 2027 Peripheral Catheter Securement Devices segment has highest cagr growth of 9.65%.

Peripheral Catheter Securement Devices

Peripheral Catheter Securement Devices segment was valued at US $0.42 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.96 billion by 2027. Peripheral Catheter Securement Devices segment represented US $0.10 billion opportunity over 2019-2021 and estimated to create US $0.44 billion opportunity in 2027 over 2021.

Central Venous Catheter Securement Devices

Central Venous Catheter Securement Devices segment was valued at US $0.27 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.61 billion by 2027. Central Venous Catheter Securement Devices segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.28 billion opportunity in 2027 over 2021.

Arterial Catheter Securement Devices

Arterial Catheter Securement Devices segment was valued at US $0.16 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.37 billion by 2027. Arterial Catheter Securement Devices segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.

Chest Drainage Tube Securement Devices

Chest Drainage Tube Securement Devices segment was valued at US $0.12 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.28 billion by 2027. Chest Drainage Tube Securement Devices segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.13 billion opportunity in 2027 over 2021.

Abdominal Drainage Tube Securement Devices

Abdominal Drainage Tube Securement Devices segment was valued at US $0.07 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.16 billion by 2027. Abdominal Drainage Tube Securement Devices segment represented US $0.02 billion opportunity over 2019-2021 and estimated to create US $0.07 billion opportunity in 2027 over 2021.

Epidural Securement Devices

Epidural Securement Devices segment was valued at US $0.04 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.10 billion by 2027. Epidural Securement Devices segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.05 billion opportunity in 2027 over 2021.

All-site Securement Devices

All-site Securement Devices segment was valued at US $0.00 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.00 billion by 2027. All-site Securement Devices segment represented US $0.00 billion opportunity over 2019-2021 and estimated to create US $0.00 billion opportunity in 2027 over 2021.

Application

Introduction

In 2021, Cardiovascular Procedures segment has the highest revenue of US $0.50 billion and is expected to grow at CAGR of 9.65% by 2027 Cardiovascular Procedures segment has highest cagr growth of 9.65%.

Cardiovascular Procedures

Cardiovascular Procedures segment was valued at US $0.41 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.94 billion by 2027. Cardiovascular Procedures segment represented US $0.09 billion opportunity over 2019-2021 and estimated to create US $0.44 billion opportunity in 2027 over 2021.

Respiratory Procedures

Respiratory Procedures segment was valued at US $0.26 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.60 billion by 2027. Respiratory Procedures segment represented US $0.06 billion opportunity over 2019-2021 and estimated to create US $0.28 billion opportunity in 2027 over 2021.

Gastric And Oropharyngeal Procedures

Gastric And Oropharyngeal Procedures segment was valued at US $0.16 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.36 billion by 2027. Gastric And Oropharyngeal Procedures segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.17 billion opportunity in 2027 over 2021.

General Surgery

General Surgery segment was valued at US $0.11 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.26 billion by 2027. General Surgery segment represented US $0.03 billion opportunity over 2019-2021 and estimated to create US $0.12 billion opportunity in 2027 over 2021.

Urological Procedures

Urological Procedures segment was valued at US $0.06 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.14 billion by 2027. Urological Procedures segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.07 billion opportunity in 2027 over 2021.

Radiology

Radiology segment was valued at US $0.05 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.11 billion by 2027. Radiology segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.05 billion opportunity in 2027 over 2021.

Other Applications

Other Applications segment was valued at US $0.03 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.06 billion by 2027. Other Applications segment represented US $0.01 billion opportunity over 2019-2021 and estimated to create US $0.03 billion opportunity in 2027 over 2021.

End User

Introduction

In 2021, Hospitals segment has the highest revenue of US $0.62 billion and is expected to grow at CAGR of 9.65% by 2027 Hospitals segment has highest cagr growth of 9.65%.

Hospitals

Hospitals segment was valued at US $0.51 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $1.16 billion by 2027. Hospitals segment represented US $0.12 billion opportunity over 2019-2021 and estimated to create US $0.54 billion opportunity in 2027 over 2021.

Homecare Settings

Homecare Settings segment was valued at US $0.23 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.52 billion by 2027. Homecare Settings segment represented US $0.05 billion opportunity over 2019-2021 and estimated to create US $0.24 billion opportunity in 2027 over 2021.

Emergency Clinics

Emergency Clinics segment was valued at US $0.18 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.40 billion by 2027. Emergency Clinics segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.19 billion opportunity in 2027 over 2021.

Diagnostic Imaging Centers

Diagnostic Imaging Centers segment was valued at US $0.17 billion in 2019 and is projected to grow at 9.65% CAGR over the forecast period to reach US $0.40 billion by 2027. Diagnostic Imaging Centers segment represented US $0.04 billion opportunity over 2019-2021 and estimated to create US $0.18 billion opportunity in 2027 over 2021.